Abstract

Avapritinib—a therapeutic breakthrough for PDGFRA D842V mutated gastrointestinal stromal tumors

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call